Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Meenhorst

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Journal of Chromatography. B, Biomedical Sciences and Applications|June 9, 1999
Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detectionA I Veldkamp, R P van Heeswijk, R M Hoetelmans, et al.
Antiviral Therapy|April 1, 1997
HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrierD M Burger, C A Boucher, P L Meenhorst, et al.
AIDS (London, England)|December 24, 1998
Comparison of the plasma pharmacokinetics and renal clearance of didanosine during once and twice daily dosing in HIV-1 infected individualsR M Hoetelmans, R P van Heeswijk, M Profijt, et al.
AIDS (London, England)|December 1, 1994
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactionsD M Burger, P L Meenhorst, C H ten Napel, et al.
AIDS (London, England)|March 29, 2001
Drug interaction between St John's wort and nevirapineM M de Maat, R M Hoetelmans, R A Math t, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluidD M Burger, H Rosing, C H ten Napel, et al.
AIDS (London, England)|October 8, 1999
The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individualsR P van Heeswijk, A I Veldkamp, R M Hoetelmans, et al.
British Journal of Clinical Pharmacology|June 26, 2001
The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individualsC H Koks, K M Crommentuyn, R M Hoetelmans, et al.
AIDS (London, England)|March 14, 2000
Itraconazole as an alternative for ritonavir liquid formulation when combined with saquinavirC H Koks, R P van Heeswijk, A I Veldkamp, et al.
Antiviral Therapy|February 22, 2000
Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapyD M Burger, R M Hoetelmans, P W Hugen, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Journal of Chromatography. B, Biomedical Sciences and Applications|June 9, 1999
Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detectionA I Veldkamp, R P van Heeswijk, R M Hoetelmans, et al.
Antiviral Therapy|April 1, 1997
HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrierD M Burger, C A Boucher, P L Meenhorst, et al.
AIDS (London, England)|December 24, 1998
Comparison of the plasma pharmacokinetics and renal clearance of didanosine during once and twice daily dosing in HIV-1 infected individualsR M Hoetelmans, R P van Heeswijk, M Profijt, et al.
AIDS (London, England)|December 1, 1994
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactionsD M Burger, P L Meenhorst, C H ten Napel, et al.
AIDS (London, England)|March 29, 2001
Drug interaction between St John's wort and nevirapineM M de Maat, R M Hoetelmans, R A Math t, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluidD M Burger, H Rosing, C H ten Napel, et al.
AIDS (London, England)|October 8, 1999
The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individualsR P van Heeswijk, A I Veldkamp, R M Hoetelmans, et al.
British Journal of Clinical Pharmacology|June 26, 2001
The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individualsC H Koks, K M Crommentuyn, R M Hoetelmans, et al.
AIDS (London, England)|March 14, 2000
Itraconazole as an alternative for ritonavir liquid formulation when combined with saquinavirC H Koks, R P van Heeswijk, A I Veldkamp, et al.
Antiviral Therapy|February 22, 2000
Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapyD M Burger, R M Hoetelmans, P W Hugen, et al.
Pageof 10